ADCendo is located in Copenhagen, Denmark on BioInnovation Institute, Ole Maaløes Vej 3. ADCendo is rated 3 out of 5 in the category pharmaceuticals in Denmark. ADCendo ApS was founded in 2017 in Copenhagen, as a spin-out from Rigshospitalet and the University of Copenhagen. The company seeks to explore novel targets in development of antibody-drug conjugates, to create new anti-cancer medicine for patients with a significant unmet need. ADCendo ApS is a resident company at Bioinnovation Institute (BII) at the Creation House level.
Address
BioInnovation Institute, Ole Maaløes Vej 3
Company size
1-10 employees
Headquarters
Copenhagen, Capital Region of Denmark